Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
09/2007
09/07/2007CA2641519A1 Compositions and methods for modulating hemostasis using variant forms of activated factor v
09/07/2007CA2614639A1 Pharmaceutical composition for treatment of blood clotting disorder
09/06/2007US20070208048 New Aryl Imidazoles and Related Compounds as C5a Receptor Modulators
09/06/2007US20070208016 1-(3-tert-butyl-4-methoxy-5-morpholinophenyl)-2-(5,6-diethoxy-7-fluoro-1-imino-1,3-dihydroisoindol-2-yl)ethanone,; stabilizing the composition; not decompose even when placed under humidification conditions
09/06/2007US20070207978 Stimulate mammalian coronary vasodilatation; imaging the heart; antiinflammatory; adjunctive therapy with angioplasty; platelet aggregation inhibitor; inhibitor of platelet and neutrophil activation;
09/06/2007US20070207957 Composition For Accelerating Alcohol Metabolism Or Relieving Fatigue By Gluconeogenesis
09/06/2007US20070207956 Stabilised solid compositions of factor VII polypeptides
09/06/2007US20070207943 Interleukins-21 and 22
09/06/2007US20070207155 Producing antibodies against platelet membrane glycoprotein VI (GPVI); for detection and treatment of thrombosis and other vascular diseases
09/06/2007US20070207140 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
09/05/2007EP1829888A1 Anti-inflammatory compounds and uses thereof
09/05/2007EP1829881A1 Combination of rapamycin and its tetrazole isomers and epimers, methods of making and using the same
09/05/2007EP1829876A1 Nitrogeneous tricyclic compound
09/05/2007EP1829550A2 Methods for treating an ischemic disorder and improving stroke outcome
09/05/2007EP1829535A2 Tissue factor antagonists and methods of use thereof
09/05/2007EP1828187A2 Crystalline forms of a factor xa inhibitor
09/05/2007EP1828118A1 Parp inhibitors
09/05/2007EP1827476A2 Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
09/05/2007EP1827386A2 Oral compositions for absorption of phosphorus compounds
09/05/2007EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
09/05/2007CN101031566A Proline derivatives
09/05/2007CN101031561A Carbonyl compounds used as coagulation factor xa inhibitor
09/05/2007CN101031549A 4-(phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists
09/05/2007CN101031548A Salts of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy) phenylmethyl) carbamide and their preparation
09/05/2007CN101031337A Extracts from roots and/or shoots of asparagus officinalis l., their preparation and their use
09/05/2007CN101031288A Medium-chain length fatty alcohols as stimulators of hematopoiesis
09/05/2007CN101029079A Production of sulfating fibroin protein and its use in anticoagulant
09/05/2007CN101029042A Bicyclic androgen and progesterone receptor modulator compounds and methods
09/05/2007CN101028487A Chinese-medicinal preparation for treating eyeground bleeding and method for inspecting vision-improving prescription quality
09/05/2007CN101028458A Tongluo Futan preparation
09/05/2007CN101028450A Medicinal composition for treating cardica cerebrovascular diseases
09/05/2007CN101028367A Tongshuan Huoluo preparation
09/05/2007CN101028307A Chinese medicine for treating liver hydroperitoneum
09/05/2007CN101028297A Chinese medicine for treating hepatic hepatic hydroperitonia
09/05/2007CN101028284A Externally-applied zeolite hemostat and its preparation
09/05/2007CN101028275A Use of alpha-D-glucose diglyceride in preparation of thrombolytic medicine
09/05/2007CN101028074A Rose essential-oil microcapsule and its production
09/05/2007CN101028060A Quelite with health-care function
09/05/2007CN101028024A Lilac health-care tea
09/05/2007CN100335897C Quality detection method for compound prepn of red sage and notoginseng
09/05/2007CN100335622C Synthesis of batroxobin gene and purification preparation of its expresson product
09/05/2007CN100335506C Heparin compound, and its preparing method and use
09/05/2007CN100335115C Therapeutic cream for dermatitis
09/04/2007US7265228 N-(alpha-methylolbenzyl)1-(aminoethyl)- or 1-(aminocarbonyl)-2-aryl(especially phenyl or benzodioxanyl)-2-hydroxyethylamine intermediates for enantiomeric synthesis of amino ceramide-like compounds
09/04/2007US7265227 Piperidine derivatives useful as modulators of chemokine receptor activity
09/04/2007US7265220 Amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
09/04/2007US7265148 Substituted pyrrole-indoles
09/04/2007US7265139 RXR activating molecules
09/04/2007US7265124 Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compound
09/04/2007US7265121 Chemical compounds
09/04/2007US7265113 Anticancer agents; antiinflammatory agents, for therapy of rheumatoid arthritis
09/04/2007US7264967 Anti-CD14 monoclonal antibody having effect of inhibiting CD14/TLR binding
09/04/2007US7264805 Proteins with a high immunoreactivity and a method for the production thereof
09/04/2007US7264798 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus
09/04/2007US7264608 Manual processing systems and methods for providing blood components conditioned for pathogen inactivation
08/2007
08/30/2007WO2007097301A1 Prophylactic or therapeutic agent for cerebral ischemia or cerebral ischemic reperfusion injury in stroke
08/30/2007WO2007096536A1 Anti-idiotypic antibody which neutralizes the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii
08/30/2007WO2007096471A1 Isoflavan and isoflavene compounds and their use as angiogenesis inhibitors
08/30/2007WO2007096116A1 Coagulation factor x polypeptides with modified activation properties
08/30/2007WO2007096088A1 Preparations effective against blemished skin and mild forms of acne with a content of hydroxymatairesinol as active principle
08/30/2007WO2006063837A8 Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
08/30/2007US20070203223 Via amino ceramide-like compounds; lowering glycosphingolipid concentrations; Fabry's disease, Gaucher's disease
08/30/2007US20070203206 2-Pyrrolidone Derivatives And Use Thereof As Factor Xa Inhibitors
08/30/2007US20070203193 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
08/30/2007US20070203141 Method for administering birb 796 bs
08/30/2007US20070203090 N-pyrazole A2A receptor agonists
08/30/2007US20070203063 Pharmaceutical compositions including variants of vascular endothelial cell growth factor having altererd pharmacological properties
08/30/2007US20070202198 Process of obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ROS scavengers, photo-protectors, biosensors biofilters and bioreactors
08/30/2007US20070202174 New mandelic acid derivatives and their use as thrombin inhibitors
08/30/2007US20070202108 Antithrombotic agents; monoclonal antibody that inhibits collagen-induced platelet aggregation at an IC50 of less than 7 mu g/ml
08/30/2007US20070202099 Antibody Drug
08/30/2007CA2643565A1 Anti-idiotypic antibody which neutralizes the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii
08/30/2007CA2642933A1 Prophylactic or therapeutic agent for cerebral ischemia or cerebral ischemic reperfusion injury in stroke
08/30/2007CA2642910A1 Coagulation factor x polypeptides with modified activation properties
08/29/2007EP1825864A2 Antithrombotic agents
08/29/2007EP1824844A1 Pyrazine dicarboxamides and the use thereof
08/29/2007EP1824477A1 Use of staurosporine derivatives for the treatment of multiple myeloma
08/29/2007EP1824468A2 Glycogen synthase kinase-3 inhibitors
08/29/2007EP1351934B1 Naphthalene derivatives which bind to the ep4 receptor
08/29/2007EP1333840B9 M. tuberculosis chaperonin 60.1 and uses thereof
08/29/2007EP1306083A4 Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion
08/29/2007CN101027063A Preventive and/or therapeutic agent for calcipenia
08/29/2007CN101024604A Novel dihydrochalcone compound separated and purified from drgon blood
08/29/2007CN101024086A Composition formed from chitosan and its derivatives and low-molecular heparin and pneparation and preparing method
08/29/2007CN101024069A Chinese medicine Chuanjia liver-toni fying powder for treating cirrhosis and ascites due to cirrhosis
08/29/2007CN101024043A Thrombus diminishing blood-pressure reducing preparation
08/29/2007CN101024039A Large-size oral dropping pills for clearing heat and Yin-tonifying and promoting blood circulation to remove stasis and preparing method
08/29/2007CN101024019A Gouzhi hemolysis soup
08/29/2007CN101023991A Thrombolysis and thrombus diminishing agent
08/29/2007CN101023946A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
08/29/2007CN101023943A Myricetin dispersion tablets for treating cardio-cerebral blood vessel diseases
08/29/2007CN101023942A Use of dihydro myricotin element for treating cardiac blood diseases
08/29/2007CN101023936A A medicine for preventing ischemic disease in a diabetic patient
08/29/2007CN101023803A Chinese wolf-berry pumpkin drink
08/29/2007CN100334076C Indoline derivatives and their use as 5-HT2 receptor ligands
08/29/2007CN100333792C Rsv基因表达疫苗 Rsv gene expression vaccine
08/29/2007CN100333785C Preparation method for eliminating thrombus and promoting lactation
08/28/2007US7262175 Anticancer agents; blood disorders
08/28/2007US7262166 Chemically modified novel erythropoietin stimulating protein compositions and methods
08/28/2007CA2504078C Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides